Carotid intima-media thickness as a marker of cardiovascular risk in patients with subclinical hypothyroidism;Espessura íntima-média carotídea como marcador de risco cardiovascular em pacientes com hipotireoidismo subclínico

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 3, 2007, Pages 472-477

  De Almeida, Carla Amaral ^a,b   Teixeira, Patrícia De F Dos S ^a   Soares, Débora V ^a   Cabral, Mônica D ^a   Da Costa, Sheila M ^a   De Salles, Elizabeth F ^a   E Silva, Nathalie A De O ^a   De Morais, Felipe F C ^a   Buescu, Alexandru ^a   Henriques, Jodélia M ^a   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiovascular; Carotid arteries; Hypothyroidism; Lipids

Indexed keywords

EID: 34250156000     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000300017     Document Type: Review

References (43)

1. Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 2001;30:245-64.
2. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-8.
3. Parle JV, Franklin JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991;34:77-83.
4. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark J. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
5. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386-8.
6. Althaus BU, Staub JJ, Ryff De Leche A, Oberhansli A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 1988;28:157-63.
7. Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995;155:1490-5.
8. Cabral MD, Costa AJL, Santos M, Vaisman M. Lipid profile in subclinical hypothyroidism. Endocrinologist 2004;14:121-5.
9. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88(6):2438-44.
10. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285(19):2486-97.
11. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in The Québec Cardiovascular Study. Circulation 1996;94:273-8.
12. Walldius G, Junger I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33.
13. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003;361:777-80.
14. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986;62:249-57.
15. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, et al. Elevated plasma lipoprotein (a) and premature coronary heart disease in Framingham men: a prospective study. JAMA 1996;276:544-8.
16. Ross R. Atherosclerosis - an inflammatoty disease. N Engl J Med 1999;340(2):115-26.
17. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonographic study in Eastern Finnish Men. J Intern Med 1991;229:225-31.
18. O'Leary DH, Polak JF. Intima-media thickness: a tool for athersoclerosis imaging and event prediction. Am J Cardiol 2002;90(suppl):18L-21.
19. Barth JD. An update on carotid ultrasound measurement of intima-media thickness. Am J Cardiol 2002;89(suppl):32B-9.
20. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1997;146:483-94.
21. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997;96:1432-7.
22. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340(1):14-22.
23. Smith SC Jr, Greenland P, Grundy SM. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention. Circulation 2000;101:111-6.
24. Salonen JT, Salonen R. Ultrasonographycally assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
25. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
26. Gnasso A, Irace C, Mattioli PL, Pujia A. Carotid intima-media thickness and coronary heart disease risk factors. Atherosclerosis 1996;119:7-15.
27. Bots ML, Mulder PGH, Hofman A, van Es, GA, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol 1993;47(8):921-30.
28. Kanters SDJM, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements. A review. Stroke 1997;28:665-71.
29. Friedwald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem, 1972;18:499-502.
30. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74(6):1399-406.
31. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93.
32. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001;86(10):4591-9.
33. Oettgen P, Ginsburg GS, Horowitz GL, Pasternak RC. Frequency of hypothyroidism in adults with serum cholesterol levels > 200 mg/dL. Am J Cardiol 1994;73:955-7.
34. Bindels AJGH, Westendorp RGJ, Frölich M, Seidell JC, Blokstra A, Smelt AHM. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case finding? Clin Endocrinol 1999;50:217-20.
35. Vierhapper H, Nardi A, Grosser P, Raber W, Gessl A. Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid 2000;10:981-4.
36. Duntas LH, Mantzou E, Koutras DA. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyrooidism. Thyroid 2002;12(11):1003-7.
37. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001;345(4):260-5.
38. Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve and thyroid antibodies. J Clin Endocrinol Metab 2002;87:3321-6.
39. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroiod disease. Scientific review and guidelines for diagnosis and management. JAMA 2004;291(2):228-38.
40. Wells BJ, Hueston WJ. Are thyroid peroxidase antibodies associated with cardiovascular disease risk in patients with subclinical hypothyroidism? Clin Endocrinol 2005;62:580-4.
41. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, et al. Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol 2003;59:607-12.
42. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 2004;89(5):2099-106.
43. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonographic study in Eastern Finnish Men. J Intern Med 1991;229:225-31.